GLSI insider transaction filings
Greenwich LifeSciences, Inc. — 45 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-30. Screen GLSI transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 3 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 3 filings by 1 insider — 7,300 shares, $97,003 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: purchase of 2,500 shares @ $13.14 ($32,850) by Patel Snehal, filed 2026-07-27.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Patel Snehal — CEO and CFO, Director, 10% owner | 3 | 5 legs · 7,300 sh · $97,003 | — | — |
Recent Form 4 filings — Greenwich LifeSciences, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-30 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 1,500 @ $13.59 · Purchase (P): 700 @ $13.10 | EDGAR |
| 2026-07-29 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 1,500 @ $13.62 | EDGAR |
| 2026-07-27 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 2,500 @ $13.14 · Purchase (P): 1,100 @ $12.88 | EDGAR |
| 2026-01-15 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 1,800 @ $29.83 | EDGAR |
| 2026-01-14 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 2,900 @ $27.54 | EDGAR |
| 2026-01-05 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 4,300 @ $21.36 | EDGAR |
| 2026-01-02 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 2,900 @ $21.73 | EDGAR |
| 2025-12-19 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 4,100 @ $12.62 | EDGAR |
| 2025-11-28 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 4,600 @ $8.37 | EDGAR |
| 2025-11-17 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-11-12 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 10,600 @ $8.43 | EDGAR |
| 2025-11-04 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 2,300 @ $9.26 | EDGAR |
| 2025-04-29 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 3,600 @ $9.88 | EDGAR |
| 2025-04-22 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 5,400 @ $8.98 | EDGAR |
| 2025-04-08 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 3,600 @ $9.10 | EDGAR |
| 2025-04-07 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 5,500 @ $8.73 | EDGAR |
| 2025-01-13 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 2,500 @ $12.51 | EDGAR |
| 2025-01-08 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 1,100 @ $13.31 · Purchase (P): 1,800 @ $13.75 | EDGAR |
| 2025-01-07 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 3,400 @ $12.95 | EDGAR |
| 2025-01-06 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 2,000 @ $11.97 | EDGAR |
| 2025-01-03 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 2,400 @ $11.36 | EDGAR |
| 2025-01-02 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 3,200 @ $11.12 | EDGAR |
| 2024-12-27 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Grant/award (A): 1,148,723 (derivative) @ $0 · Grant/award (A): 25,008 (derivative) @ $0 | EDGAR |
| 2024-12-27 | 4 | Hallock Kenneth — Director | Grant/award (A): 41,349 (derivative) @ $0 | EDGAR |
| 2024-12-27 | 4 | Daugherty Frank Joseph — Chief Medical Officer, Director | Grant/award (A): 104,890 (derivative) @ $0 | EDGAR |
| 2024-12-27 | 4 | Rothe Eric — Director | Grant/award (A): 41,349 (derivative) @ $0 | EDGAR |
| 2024-12-27 | 4 | Thompson Jaye — VP Clinical Reg Affairs | Grant/award (A): 149,818 (derivative) @ $0 | EDGAR |
| 2024-12-27 | 4 | McWilliams David — Director | Grant/award (A): 61,984 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | Thompson Jaye — VP Clinical Reg Affairs | Purchase (P): 1,000 @ $12.91 | EDGAR |
| 2024-09-30 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 1,500 @ $14.63 | EDGAR |
| 2024-09-16 | 4 | Thompson Jaye — VP Clinical Reg Affairs | Purchase (P): 800 @ $13.85 | EDGAR |
| 2024-08-08 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 2,000 @ $13.81 | EDGAR |
| 2024-08-07 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 5,500 @ $13.18 | EDGAR |
| 2024-08-05 | 4 | Thompson Jaye — VP Clinical Reg Affairs | Purchase (P): 1,000 @ $15.15 | EDGAR |
| 2024-07-24 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 1,500 @ $15.89 | EDGAR |
| 2024-07-22 | 4 | Thompson Jaye — VP Clinical Reg Affairs | Purchase (P): 1,000 @ $16 | EDGAR |
| 2024-06-17 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 174,825 @ $14.30 | EDGAR |
| 2024-04-03 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 3,000 @ $19.08 | EDGAR |
| 2024-03-26 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 2,500 @ $19.98 | EDGAR |
| 2024-03-22 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 1,500 @ $17.68 | EDGAR |
| 2024-03-07 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 30,500 @ $12.49 | EDGAR |
| 2024-03-07 | 4/A | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 3,500 @ $12.49 | EDGAR |
| 2024-03-06 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 4,100 @ $13.03 | EDGAR |
| 2024-02-21 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 10,800 @ $11.16 | EDGAR |
| 2024-02-20 | 4 | Patel Snehal — CEO and CFO, Director, 10% owner | Purchase (P): 12,700 @ $11.07 | EDGAR |
Recent 8-K events — Greenwich LifeSciences, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-12-18 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-07-24 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-12-19 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2024-06-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-20 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GLSI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →